Toronto, ON – January 28, 2013 – Prostate Cancer Canada (PCC) is proud to announce the recipients of the Rising Star in Prostate Cancer Research program. In its inaugural year, the Movember-funded Rising Star program provides funding to four outstanding scientists to support careers as independent investigators researching prostate cancer.
The breakthrough collaborative work being done by Drs. Colin Collins and Yuzhuo Wang of the Vancouver Prostate Centre is featured in a three-page article in the latest issue of "International Innovation" magazine.
Click here to view the whole article as a PDF.
Movember, the month-long fundraiser for men's health, has begun. The funds raised in Canada support men's health issues, specifically prostate cancer and male mental health initiatives. The funds raised are directed to programs run directly by Movember and their men’s health partner, Prostate Cancer Canada.
Many men survive prostate cancer, but thousands of others — whose cancer spreads — inevitably develop resistance to even the most promising treatments, leaving them with few medical options and a dwindling span of life.
Now, armed with a new $10 million grant, a multi-centre “dream team’’ of scientists is embarking on a groundbreaking undertaking into personalized medicine. The goal: to overcome therapeutic resistance in the disease and revolutionize treatment for patients with advanced prostate cancer.
A three-minute clip on the Vancouver Prostate Centre and one of our novel approaches to designing therapeutic drugs was featured on Global TV evening news on Monday September 17, 2012. The video includes interviews with patient Don Konantz and research scientists Dr. Colin Collins and Dr. Artem Cherkazov. Watch the clip here (a short advertisement plays before the news clip).
Monday September 17, 2012
Vancouver, BC – Researchers at the Vancouver Prostate Centre at Vancouver Coastal Health and UBC are undertaking a revolutionary approach to find new drug therapies and molecular targets that will help prostate cancer patients who have become resistant to treatment.
A new study co-authored by Dr. Larry Goldenberg, urologic surgeon and researcher at the Vancouver Prostate Centre and head of the Department Urologic Sciences at UBC, has shown that prostate cancer patients who are given a “drug holiday” have the same survival rate as the continuous treatment group, and a far better quality of life.
Drs. Martin Gleave and Colin Collins part of new pan-Canadian prostate cancer network
A new pan-Canadian network of prostate cancer researchers formed by the Terry Fox Research Institute (TFRI) aims to address this need with approximately $4-million provided by the Terry Fox Foundation and the Canadian Partnership Against Cancer. The funding was announced today at the CHUM Research Centre (CRCHUM).
Congratulations to Dr. Amina Zoubeidi for being one of nine recipients of the 2012 Career Investigator Award, Scholar (Biomedical) from the Michael Smith Foundation for Health Research. Click here for further information.